Skip to main content
Log in

It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

The purpose of this study was the evaluation of the necessity of routinely applied postoperative radiotherapy in a highly selected patient-group after breast conserving surgery. Between 1983 and May 1994, 356 women over 60 years of age with Stage I or II breast cancer were treated by quadrantectomy and axillary dissection followed by either adjuvant irradiation or no radiotherapy. We have analysed our data retrospectively to investigate whether irradiation has any benefit in elderly patients with respect to locoregional recurrence rates. After a median follow-up of 60 months the multivariate model revealed lymph node status (p=0.002) as highly significant with regard to local recurrence free survival. We were not able to identify a positive effect of adjuvant irradiation in patients with negative lymph nodes and positive receptor status: both patient groups with or without irradiation had similar locoregional recurrence rates of 3%. In a subgroup of patients who were lymph node negative, receptor positive, and received adjuvant tamoxifen therapy, the local recurrence rates were as low as 2% in both groups. Concerning these results it may be possible to avoid the morbidity and potential psychological side effects of radiotherapy in breast cancer patients over 60 years of age treated by breast conserving surgery (T1, N0, positive hormone receptor, adjuvant tamoxifen) without increasing risk of locoregional recurrence. These data have to be confirmed in a prospectively randomized fashion.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, Fisher ER, Wolmark N, Deutsch M, Montague E, Saffer E, Wickerham L, Lerner H, Glass A, Shibata H, Deckers P, Ketcham A, Oishi R, Russell I: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312: 665–673, 1985

    Google Scholar 

  2. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerham L, Fisher ER, Deutsch M, Caplan R, Pilch Y, Glass A, Shibata H, Lerner H, Terz J, Sidorovich L: Eight-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320: 822–828, 1989

    Google Scholar 

  3. Veronesi U, Banfi A, Salvadori B, Luini A, Saccozzi R, Zucali R, Marubini E, Del Vecchio M, Boracchi P, Marchini S, Merson M, Sacchini V, Riboldi G, Santoro G: Breast conservation is the treatment of choice in small breast cancer: long-term results of a randomized trial. Eur J Cancer 26: 668–670, 1990

    Google Scholar 

  4. Veronesi U, Volterrani F, Luini A, Saccozzi R, Del Vecchio M, Zucali R, Galimberti V, Rasponi A, Di Re E, Squicciarini P, Salvadori B: Quadrantectomy versus lumpectomy for small size breast cancer. Eur J Cancer 26: 671–673, 1990

    Google Scholar 

  5. Fisher B, Anderson S, Fisher ER, Redmond C, Wickerham DL, Wolmark N, Mamounas EP, Deutsch M, Margolese R: Significance of ipsilateral breast tumor recurrence after lumpectomy. Lancet 338: 327–331, 1991

    Google Scholar 

  6. Veronesi U, Luini A, Del Vecchio M, Greco M, Galimberti V, Merson M, Rilke F, Sacchini V, Saccozzi R, Savio T, Zucali R, Zurrida S, Salvadori B: Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 328: 1587–1591, 1993

    Google Scholar 

  7. Hermann RE, Esselstyn CB, Grundfest-Broniatowski S, Steiger E, Vogt DP, Broughan TA, Dowden RV, Hardesty I, Medendrop SV, Boyett JM: Partial mastectomy without radiation is adequate treatment for patients with Stage 0 and 1 carcinoma of the breast. Surg Gyn Obst 177: 247–253, 1993

    Google Scholar 

  8. Liljegren G, Homberg L, Adami HO, Westerman G, Graffman S, Bergh J: Sector resection with or without postoperative radiotherapy for Stage I breast cancer: five-year results of a randomized trial. J Natl Cancer Inst 86: 717–722, 1994

    Google Scholar 

  9. Locker AP, Ellis IO, Morgan DAL, Elston CW, Mitchell A, Blamey RW: Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 76: 890–894, 1989

    Google Scholar 

  10. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63: 181–187, 1989

    Google Scholar 

  11. Clark RM, McCulloch PB, Levine MN, Lipa M, Wilkinson RH, Mahoney LJ, Basrur VR, Nair BD, McDermot RS, Wong CS, Corbett PJ: Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst 84: 683–689, 1992

    Google Scholar 

  12. Greening WP, Montgomery ACV, Gordon AB, Growing NFC: Quadrantic excision and axillary node dissection without radiation therapy: the long-term results of a selective policy in the treatment of Stage I breast cancer. Eur J Surg Onc 14: 221–225, 1988

    Google Scholar 

  13. Fisher ER, Anderson S, Redmond C, Fisher B: Ipsilateral breast tumor recurrence and survival following lumpectomy and irradiation: pathological findings from NSABP Protocol B-06. Sem Surg Onc 8: 161–166, 1992

    Google Scholar 

  14. Kurtz JM, Jacquemier J, Amalric R, Brandone H, Ayme Y, Hans D, Bressac C, Roth J, Spitalier JM: Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 65: 1867–1878, 1990

    Google Scholar 

  15. Fourquet A, Campana F, Zafrani B: Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up. Int J Radiat Oncol Biol Phys 17: 719–725, 1989

    Google Scholar 

  16. Borger J, Kemperman H, Hart A, Peterse H, van Dongen J, Bartelink H: Risk factors in breast-conservation therapy. J Clin Oncol 12: 653–660, 1994

    Google Scholar 

  17. Schnitt SJ, Connolly JL, Harris JR, Hellman S, Cohen RB: Pathological predictors of early recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer 53: 1049–1057, 1984

    Google Scholar 

  18. Fisher ER, Redmond C, Fisher B, Bass G: Pathologic findings from the National Surgical Adjuvant Breast and Bowel Projects (NSABP). Cancer 65: 2121–2128, 1990

    Google Scholar 

  19. Fisher B, Constantino J, Redmond C, Poisson R, Bowman D, Couture J, Dimitrov NV, Wolmark N, Wickerham DL, Fisher ER, Margolese R, Robidoux A, Shibata H, Terz J, Paterson AHG, Feldman MI, Farrar W, Evans J, Lickley HL, Ketner M: A randomized clinical trial evaluating Tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors. N Engl J Med 320: 479–484, 1989

    Google Scholar 

  20. Holland R, Connolly JL, Gelman R, Mravunac M, Hendriks J, Verbeek A, Schnitt SJ, Silver B, Boyages J, Harris JR: The presence of an intraductal component following a limited excision correlates with prominent residual disease in the remainder of the breast. J Clin Oncol 8: 113–118, 1990

    Google Scholar 

  21. Clemente CG, Boracchi P, Andreola S, Del Vecchio M, Veronesi P, Rilke FO: Peritumoral lymphatic invasion in patients with node-negative mammary duct carcinoma. Cancer 69: 1396–1403, 1992

    Google Scholar 

  22. Gruenberger Th, Gorlitzer M, Soliman Th, Rudas M, Mittlboeck M, Goetzinger P, Gnant M, Reiner A, Teleky B, Seitz W, Jakesz R: Kann man einer hochselektionierten Patientinnengruppe nach brusterhaltender Therapie wegen Mammakarzinoms die postoperative Nachbestrahlung ersparen? Acta Chirurgica Austriaca 27: 269–273, 1995

    Google Scholar 

  23. Nemoto T, Patel JK, Rosner D, Dao TL, Schuh M, Penetrante R: Factors affecting recurrence in lumpectomy without irradiation for breast cancer. Cancer 67: 2079–2082, 1991

    Google Scholar 

  24. Recht A, Houlihan MJ: Conservative surgery without radiotherapy in the treatment of patients with early-stage invasive breast cancer. Ann Surg 222: 9–18, 1995

    Google Scholar 

  25. Reiner A, Spona J, Reiner G: Estrogen receptor analysis on biopses and fine-needle aspirates from human breast carcinoma. Am J Pathol 125: 443–449, 1986

    Google Scholar 

  26. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM: Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 333: 1456–1461, 1995

    Google Scholar 

  27. Clark RM, Whelan T, Levine M, Roberts R, Willan A, McCulloch P, Lipa M, Wilkinson RH, Mahoney LJ: Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst 88: 1659–1664, 1996

    Google Scholar 

  28. Forrest AP, Stewart HJ, Everington D, Prescott RJ, McArdle CS, Harnett AN, Smith DC: Randomized controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Lancet 348: 708–713, 1996

    Google Scholar 

  29. Liljegren G, Lindgren A, Bergh J, Nordgren H, Tabar L, Holmberg L: Risk factors for local recurrence after conservative treatment in stage I breast cancer. Definition of a subgroup not requiring radiotherapy. Ann Oncology 8: 235–241, 1997

    Google Scholar 

  30. Moffat FL, Ketcham AS, Robinson DS, Legaspi A, Ghandur-Mnaymneh L, Hilsenbeck S: Segmental mastectomy without radiotherapy for T1 and small T2 breast carcinomas. Arch Surg 125: 364–369, 1990

    Google Scholar 

  31. Cady B, Stone MD, Wayne J: New therapeutic possibilities in primary invasive breast cancer. Ann Surg 218: 338–349, 1993

    Google Scholar 

  32. Dalberg K, Mattsson A, Rutqvist LE, Johansson U, Riddez L, Sandelin K: Breast conserving surgery for invasive breast cancer: Risk factors for ipsilateral breast tumor recurrences. Breast Cancer Res Treat 43: 73–86, 1997

    Google Scholar 

  33. van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Tong D, Winter J, van Zijl K: Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer 28A(4/5): 801–805, 1992

    Google Scholar 

  34. Stewart HJ, Prescott RJ, Forrest PA: Conservation therapy of breast cancer. Lancet ii 168–169, 1989

    Google Scholar 

  35. Early Breast Cancer Trialists' Collaborative Group: Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. Lancet 339: 71–85, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gruenberger, T., Gorlitzer, M., Soliman, T. et al. It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patients. Breast Cancer Res Treat 50, 37–46 (1998). https://doi.org/10.1023/A:1006064608360

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1006064608360

Navigation